当前位置: 首页 > 期刊 > 《中国医学创新》 > 2024年第7期
编号:1629207
中医药对免疫抑制剂治疗肺病不良反应干预策略
http://www.100md.com 2024年5月21日 中国医学创新 2024年第7期
     许敏 赵旭涛 张群

    【摘要】 大多数免疫抑制剂对人体免疫系统没有选择性和特异性的抑制作用,因此会增加恶性肿瘤、感染、骨髓抑制等不良反应的发生率。而中医药干预不良反应有着较为明显的效果,在临床实践中采用中药联合免疫抑制剂的综合治疗也取得了一定的成效。本文主要综述应用免疫抑制剂后产生肺部不良反应的中医药干预,为进一步研究提供参考。

    【关键词】 免疫抑制剂 不良反应 中医药 肺部疾病 免疫反应

    Intervention Strategy of Traditional Chinese Medicine on Pulmonary Adverse Reactions of Immunosuppresant/XU Min, ZHAO Xutao, ZHANG Qun. //Medical Innovation of China, 2024, 21(07): 183-188

    [Abstract] Most immunosuppressant have no selective and specific inhibition on the human immune system, so they will increase the incidence of malignant tumor, infection, bone marrow supression and other adverse reactions. However, traditional Chinese medicine intervention has a relatively obvious effect on adverse reactions, and the comprehensive treatment of Chinese materia medica combined with immunosuppressant has also achieved certain results in clinical practice. This article mainly reviews the traditional Chinese medicine intervention of pulmonary adverse reactions after the application of immunosuppressant, and provides reference for further research.

    [Key words] Immunosuppressant Adverse reaction Traditional Chinese medicine Pulmonary disease Immunology response ......

您现在查看是摘要页,全文长 16391 字符